AVR 1.73% $17.05 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-60

  1. 1,142 Posts.
    lightbulb Created with Sketch. 1
    I get the result. If the result is good enough to have it divested to another group for significant use, however, I am all for it. I think this company is all about medical devices and CC going forward. For the next few years at least.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.05
Change
-0.300(1.73%)
Mkt cap ! $327.7M
Open High Low Value Volume
$17.00 $17.44 $16.95 $184.6K 10.84K

Buyers (Bids)

No. Vol. Price($)
1 191 $17.15
 

Sellers (Offers)

Price($) Vol. No.
$17.50 500 1
View Market Depth
Last trade - 15.59pm 19/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.